TIME
Doctors are more divided than ever over the safety of prescribing antidepressant drugs–Prozac, Paxil and Zoloft and other so-called selective serotonin-reuptake inhibitors (SSRIs)–to depressed children and teens. British health-care officials last month warned doctors against giving any SSRI but Prozac to kids, citing studies that suggest the drugs may trigger suicidal behavior. The FDA issued a similar warning against Paxil but held off on the other SSRIs pending further study. Now an American College of Neuropsychopharmacology task force, having reviewed the data, says the link to suicide is weak and that the drugs’ benefits outweigh the risks. The FDA plans to revisit the issue next month.
More Must-Reads from TIME
- Introducing the 2024 TIME100 Next
- Sabrina Carpenter Has Waited Her Whole Life for This
- What Lies Ahead for the Middle East
- Why It's So Hard to Quit Vaping
- Jeremy Strong on Taking a Risk With a New Film About Trump
- Our Guide to Voting in the 2024 Election
- The 10 Races That Will Determine Control of the Senate
- Column: How My Shame Became My Strength
Contact us at letters@time.com